DE60219926D1 - Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma - Google Patents

Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma

Info

Publication number
DE60219926D1
DE60219926D1 DE60219926T DE60219926T DE60219926D1 DE 60219926 D1 DE60219926 D1 DE 60219926D1 DE 60219926 T DE60219926 T DE 60219926T DE 60219926 T DE60219926 T DE 60219926T DE 60219926 D1 DE60219926 D1 DE 60219926D1
Authority
DE
Germany
Prior art keywords
plasma
active substance
protein population
unwanted protein
unwanted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60219926T
Other languages
English (en)
Other versions
DE60219926T2 (de
Inventor
Mark B Pepys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentraxin Therapeutics Ltd
Original Assignee
Pentraxin Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119370.5A external-priority patent/GB0119370D0/en
Application filed by Pentraxin Therapeutics Ltd filed Critical Pentraxin Therapeutics Ltd
Publication of DE60219926D1 publication Critical patent/DE60219926D1/de
Application granted granted Critical
Publication of DE60219926T2 publication Critical patent/DE60219926T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
DE60219926T 2001-08-08 2002-07-29 Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma Expired - Lifetime DE60219926T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US985699 1997-12-05
GBGB0119370.5A GB0119370D0 (en) 2001-08-08 2001-08-08 Therapeutic agent
GB0119370 2001-08-08
US09/985,699 US7045499B2 (en) 2001-08-08 2001-11-05 Therapeutic agent
PCT/GB2002/003504 WO2003013508A1 (en) 2001-08-08 2002-07-29 Therapeutic agent for depletion of an unwanted protein population from plasma

Publications (2)

Publication Number Publication Date
DE60219926D1 true DE60219926D1 (de) 2007-06-14
DE60219926T2 DE60219926T2 (de) 2007-11-22

Family

ID=26246416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219926T Expired - Lifetime DE60219926T2 (de) 2001-08-08 2002-07-29 Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma

Country Status (8)

Country Link
US (2) US7691897B2 (de)
EP (1) EP1418905B1 (de)
JP (1) JP4472333B2 (de)
AT (1) ATE361068T1 (de)
DE (1) DE60219926T2 (de)
DK (1) DK1418905T3 (de)
ES (1) ES2284895T3 (de)
WO (1) WO2003013508A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390795B2 (en) 2000-12-18 2008-06-24 Pentraxin Therapeutics Limited Treatment and prevention of tissue damage
DE60219926T2 (de) 2001-08-08 2007-11-22 Pentraxin Therapeutics Ltd. Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
GB0211136D0 (en) * 2002-05-15 2002-06-26 Univ London Treatment and prevention of tissue damage
GB0313386D0 (en) 2003-06-10 2003-07-16 Univ London Treatment of disease
AU2008232254A1 (en) * 2007-03-23 2008-10-02 The Governors Of The University Of Alberta Multivalent heterobifunctional polymers and methods of their use
GB0718718D0 (en) 2007-09-25 2007-11-07 Pentraxin Therapeutics Ltd Compound and use thereof
US9886546B2 (en) 2012-11-20 2018-02-06 General Electric Company Methods and apparatus to label radiology images
KR102522730B1 (ko) * 2016-06-29 2023-04-19 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 디프로보심: 새로운 강력한 부류의 tlr 작용제
EP3829571A4 (de) * 2018-08-02 2022-04-27 The Board Of Regents Of The University Of Texas System Adjuvante wirkung des tlr1/2-agonisten diprovocim in synergie mit checkpoint-hemmenden antikörpern zur bekämpfung von krankheiten
GB202014589D0 (en) 2020-09-16 2020-10-28 Ucl Business Ltd Agents for use in the treatment of amyloidosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277352A (ja) * 1986-01-30 1987-12-02 Ono Pharmaceut Co Ltd 新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤
US4895872A (en) * 1989-03-15 1990-01-23 Cetus Corporation Immunosupressive analogues and derivatives of succinylacetone
JPH0667472B2 (ja) * 1988-11-28 1994-08-31 鐘淵化学工業株式会社 血清アミロイドｐ蛋白用吸着体
EP0691844A1 (de) * 1993-03-29 1996-01-17 Queen's University At Kingston Verfahren zur behandlung von amyloidosis
GB9317120D0 (en) 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
US6172045B1 (en) * 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
CA2287569A1 (en) 1997-05-02 1998-11-12 Akzo Nobel Nv Serine protease inhibitors
US6365570B1 (en) * 1997-10-10 2002-04-02 Universiteit Utrecht Pharmaceutical and diagnostic use of Serum Amyloid P component
DK0915088T3 (da) * 1997-10-31 2003-01-27 Hoffmann La Roche D-prolinderivater
GB0119370D0 (en) * 2001-08-08 2001-10-03 Univ London Therapeutic agent
DE60219926T2 (de) * 2001-08-08 2007-11-22 Pentraxin Therapeutics Ltd. Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
GB0313386D0 (en) 2003-06-10 2003-07-16 Univ London Treatment of disease

Also Published As

Publication number Publication date
US8173694B2 (en) 2012-05-08
EP1418905A1 (de) 2004-05-19
US20060122124A1 (en) 2006-06-08
ATE361068T1 (de) 2007-05-15
JP4472333B2 (ja) 2010-06-02
DK1418905T3 (da) 2007-09-10
DE60219926T2 (de) 2007-11-22
EP1418905B1 (de) 2007-05-02
ES2284895T3 (es) 2007-11-16
JP2005501071A (ja) 2005-01-13
WO2003013508A1 (en) 2003-02-20
US7691897B2 (en) 2010-04-06
US20100173969A1 (en) 2010-07-08

Similar Documents

Publication Publication Date Title
DE60212663D1 (de) Dermales system zur wirkstoffabgabe
DE60132089D1 (de) Vorrichtung zur behandlung von gasen miitels plasma
DE69526516T2 (de) Vorrichtung zur verabreichung von peptidwirkstoffen in aerosolform
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69941280D1 (de) Vorrichtung zur Behandlung von Stenosen an Verzweigungen
DE59610127D1 (de) Vorrichtung zur Entfernung von toxischen Stoffen aus Blut
DE60239554D1 (de) Medizinische vorrichtung zur abgabe von pflastern
DE69633294T8 (de) Gerät zur infusion und aspiration in, bzw. aus knochen
AU2003296945A1 (en) Device and method for in-line blood testing using biochips
AU2002243879A1 (en) Integrated blood handling system having active gas removal system and methods of use
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
PL371736A1 (en) Method for administering glp-1 molecules
DE60107936D1 (de) Vorrichtung und verfahren zur handhabung von ophthalmischen linsen
DE60219926D1 (de) Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
ATE481104T1 (de) Mittel zur behandlung von flaviviridae- infektionen
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
MXPA04002001A (es) Procedimiento para entresacado de frutos.
DE69934777D1 (de) Substanz aktivirendes verfahren-und vorrichtung
DE50108409D1 (de) Behandlung von oberflächen zur temporären verbesserung des schmutzablöseverhaltens
DE50214617D1 (de) Vorrichtung zur behandlung von histologischen proben
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE60034779D1 (de) Insulinartiger-wachstumsfaktorbindungsprotein-4-protease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition